Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/tid.13348

http://scihub22266oqcxt.onion/10.1111/tid.13348
suck pdf from google scholar
32500936!7300504!32500936
unlimited free pdf from europmc32500936    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32500936      Transpl+Infect+Dis 2020 ; 22 (6): e13348
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Case series of six kidney transplanted patients with COVID-19 pneumonia treated with tocilizumab #MMPMID32500936
  • Mella A; Mingozzi S; Gallo E; Lavacca A; Rossetti M; Clari R; Randone O; Maffei S; Salomone M; Imperiale D; Biancone L
  • Transpl Infect Dis 2020[Dec]; 22 (6): e13348 PMID32500936show ga
  • Few reports described the outcome of kidney transplanted patients (KTs) affected by COVID-19 treated with interleukin-6 receptor inhibitor tocilizumab (TCZ). We report our case series of 6 KTs with COVID-19 pneumonia who received TCZ: All were of male gender, with a mean age of 55.5 +/- 8.4 years, a median time from transplantation of 3611 days (1465-5757); 5/6 had cardiovascular comorbidities, 1/6 had diabetes, and 3/6 have one or more previous KTs. Four out of six patients died, at an average time of 9.75 +/- 2.4 days after tocilizumab administration, 3/6 due to a coexistent septic shock. Two patients improved after TCZ and were discharged at 20 and 21 days, respectively; in both patient, a significant increase of total lymphocyte count was observed. In conclusion, KTs, where the role of peculiar factors such as chronic immunosuppression is still undetermined, represent a high-risk group with significant COVID-19-associated mortality. The evaluation of the TCZ effect in COVID-19 pneumonia requires controlled studies (ideally RCTs) in this specific population.
  • |*COVID-19 Drug Treatment[MESH]
  • |*Kidney Transplantation[MESH]
  • |Acute Kidney Injury/therapy[MESH]
  • |Adult[MESH]
  • |Aged[MESH]
  • |Anti-Bacterial Agents/therapeutic use[MESH]
  • |Antibodies, Monoclonal, Humanized/*therapeutic use[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |C-Reactive Protein/immunology[MESH]
  • |COVID-19/immunology/mortality[MESH]
  • |Continuous Renal Replacement Therapy[MESH]
  • |Enzyme Inhibitors/therapeutic use[MESH]
  • |Graft Rejection/*prevention & control[MESH]
  • |Humans[MESH]
  • |Hydroxychloroquine/therapeutic use[MESH]
  • |Immunocompromised Host/*immunology[MESH]
  • |Immunosuppressive Agents/*therapeutic use[MESH]
  • |Leukocyte Count[MESH]
  • |Lymphocyte Count[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box